PFIZER, INC.

(PFE)
  Report
Real-time Estimate Cboe BZX  -  05/16 03:46:49 pm EDT
50.65 USD   +1.45%
11:52aGLOBAL MARKETS LIVE : Pfizer, Tesla, Holcim, Novartis, Ford...
10:39aWALL STREET STOCK EXCHANGE : China added to the list of investors' fears
08:08aPfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European Commission
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pzifer, OPKO Health Evaluating FDA's Complete Response Letter on Growth Hormone Replacement

01/21/2022 | 04:46pm EDT


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
OPKO HEALTH, INC. -0.83% 2.955 Delayed Quote.-37.01%
PFIZER, INC. 1.43% 50.835 Delayed Quote.-15.46%
All news about PFIZER, INC.
11:52aGLOBAL MARKETS LIVE : Pfizer, Tesla, Holcim, Novartis, Ford...
10:39aWALL STREET STOCK EXCHANGE : China added to the list of investors' fears
08:08aPfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European C..
AQ
07:11aINSIDER SELL : Pfizer
MT
05/15Pfizer, BioNTech Agree To Move Delivery Schedules For COVID-19 Vaccines In EU
MT
05/13Pfizer Files Lawsuit In Australia To Halt Sales Of BRENZYS (Etanercept)
AQ
05/13N.Korea gets offers of aid to fight COVID as it lacks vaccines
RE
05/12PFIZER, INC. : Ex-dividend day for
FA
05/11PFIZER INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF ..
AQ
05/11Pfizer's $11.6 billion Biohaven buy could spark more biotech deals
RE
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2022 104 B - -
Net income 2022 35 223 M - -
Net cash 2022 10 478 M - -
P/E ratio 2022 8,35x
Yield 2022 3,25%
Capitalization 280 B 280 B -
EV / Sales 2022 2,59x
EV / Sales 2023 3,40x
Nbr of Employees 79 000
Free-Float 58,2%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 49,92 $
Average target price 57,79 $
Spread / Average Target 15,8%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
David M. Denton Chief Financial Officer & Executive Vice President
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-15.46%280 096
JOHNSON & JOHNSON3.38%465 363
ABBVIE INC.13.37%271 251
ELI LILLY AND COMPANY5.58%262 514
ROCHE HOLDING AG-15.85%258 421
NOVO NORDISK A/S1.92%238 221